C2i Genomics vs Nucleix
C2i Genomics vs Nucleix, compared side by side on 23 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: C2i Genomics is on 62/100 and Nucleix on 56/100.
Where each one leads
C2i Genomics
- our overall score: 62/100 against 56/100
- domain rating: 63/100 against 38/100
Nucleix
- headcount: 74 against 17
- headcount growth: +7.1% against -20.8%
At a glance
| Measure | C2i Genomics | Nucleix |
|---|---|---|
| What it is | Comprehensive whole-genome monitoring for cancer recurrence and progression. | Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis. |
| Category | Healthcare, Genomics, Cancer, Tumor Detection | Healthcare, Lung, Bladder, Cancer |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2018 | 2008 |
| Headquarters | Tel Aviv, Israel | Rehovot, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | C2i Genomics | Nucleix |
|---|---|---|
| Employees | 17 | 74 |
| Headcount growthLast 12 months | -20.8% | +7.1% |
| Total funding | $112M | $102M |
| Latest round | Series B | Funding Round |
| LinkedIn followers | 6,366 | 7,846 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | C2i Genomics | Nucleix |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 56/100 |
| Traction | 53/100 | 59/100 |
| Team | 90/100 | 70/100 |
| Search visibility | 35/100 | 36/100 |
| Quality | 65/100 | 55/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (30/100) | F (30/100) |
| Domain ratingLink authority, 0-100 | 63/100 | 38/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | C2i Genomics | Nucleix |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Bootstrap | Jquery |
| Analytics | Google Analytics 4, Google Tag Manager | Google Analytics 4 |
What users say
| Measure | C2i Genomics | Nucleix |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 6 positive, 0 negative across 6 threads |
“Nucleix Demonstrates Potential of its PCR EpiCheck® Assay to Accurately Differentiate Between Small Cell Lung Cancer (SCLC) Subtypes.”r/LungCancerSupport
C2i Genomics vs Nucleix: common questions
Which is better, C2i Genomics or Nucleix?
On our 0-100 score C2i Genomics rates higher (62/100 against 56/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 23 data points above: read the rows that match what you are buying for.
How do C2i Genomics and Nucleix compare on the numbers?
C2i Genomics leads on our overall score (62/100 against 56/100), domain rating (63/100 against 38/100). Nucleix leads on headcount (74 against 17), headcount growth (+7.1% against -20.8%).
What do real users say about C2i Genomics and Nucleix?
Nucleix: 6 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/LungCancerSupport.
Read the full C2i Genomics review and pricing or the Nucleix review and pricing. You can also browse other C2i Genomics alternatives we track.